HIV Lab Monitoring Guidelines PDF
Document Details
![EventfulMahoganyObsidian2751](https://quizgecko.com/images/avatars/avatar-2.webp)
Uploaded by EventfulMahoganyObsidian2751
Dasmesh School Winnipeg
Tags
Related
- HIV & Retroviruses Microbiology, Pathogenesis, Opportunistic Infections, & Antiretrovirals PDF
- HIV & AIDS Nursing Notes PDF
- Immunity: HIV/AIDS: SLE Practice Exam PDF
- HIV/AIDS/Immunity Quiz PDF
- HIV Opportunistic Infections PDF
- British HIV Association Guidelines on Pulmonary Opportunistic Infections 2024 PDF
Summary
This document provides guidelines for monitoring patients with HIV, focusing on opportunistic infections (OIs) and their prevention based on CD4 cell counts. The document details various OIs such as thrush, oral hairy leukoplakia, TB, and others, along with their associated CD4 thresholds for prophylaxis. The material also includes primary prevention strategies.
Full Transcript
# Lab monitoring | Monitoring parameter | Goal | When to check | |---|---|---| | VL | Undetectable (< 20 c/mL) | • Baseline • 4-8 wks after initiating ART • Recheck q 4-8 wk until undetectable • q 3-6 mo once undetectable | | CD4 (+ CBC with diff) | As high as possible •>200 cells/mm³ | • Baseli...
# Lab monitoring | Monitoring parameter | Goal | When to check | |---|---|---| | VL | Undetectable (< 20 c/mL) | • Baseline • 4-8 wks after initiating ART • Recheck q 4-8 wk until undetectable • q 3-6 mo once undetectable | | CD4 (+ CBC with diff) | As high as possible •>200 cells/mm³ | • Baseline, then q 3-6 mo. • may reduce to q 12 mo if CD4 >300 • optional if CD4 >500 & on ART | | Lytes, SCr, glucose, AST, ALT, Tbili, Lipid profile | Normal | • Baseline • 4-8 wks after initiating ART • q 3-6 mo. Thereafter | | Serum PO4 (for pts with CKD, DM on TDF) | Normal | • Baseline • yearly thereafter | # Predicting Ol risk -> Risk of Ols increase as CD4 count decreases -> Generally once CD4 < 200, Ol prophylaxis should be started -> REMEMBER some patients get sick from non-Ol pathogens too -> AB prophylaxis reduces incidence of Ol > * Primary prevention: Prevent first disease ep. > * Secondary ppx: preventing reactivation or recurrence of an infection after it has been treated > > * Sometimes necessary to use secondary ppx until CD4 increases above infection threshold # Common Ol's -> CD4 < 400 * **Thrush** * Candida Albicans * Yeast * GI tract; oropharyngeal and vaginal infections * Easily removable “plaque” on tongue * RX; Fluconzole * Nystatin * **Oral Hairy Leukoplasia** * Virus-Can cause other infections + malignancies * Non-Hodgkin Lymphoma * White hairy patches on tongue * Looks IDENTICAL to thrush * But much harder to remove -> CD4 < 200 * **TB** * Mycobacterium TB * Reactivation occurs v. soon after HIV infection-any CD4 * Routine testing: TST or IGRA at HIV dx. * Tx Latent TB and close contacts of known TB case * Atypical Presentation when CD4 < 350 * Rx. same as non-HIV * **Bacteria** * Streptococcus Pneumoniae * Community acquired pneumonia * Rx: Same as non-HIV * **Pneumocystis jiroveci (PJP)** * Unicellular Fungus * Causes disease almost exclusively in lungs * Symptoms are slow and insidious-subacute presentation common in Ol's * Fever * Progressive dyspnea * Non-productive cough * Wheeze * Hypoxia * CXR: Diffuse, bilateral interstitial (or alveolar) infiltrates * Dx: Sputum induction, BAL (w/silver staining) * Most common in Ol in N. America * Primary ppx occurs when CD4 < 200 -> CD4 < 100 * **HSV** * Herpes Simplex Virus * Orolabial and genital infections * Episodic Tx should be initiated at first tingle * Valacyclovir, Famicclovir, acyclovir * Suppressive Tx. indicated for frequent recurrences * **Candida Esophagitis** * Candida albicans * May be quite painful to swallow, anorexia * Requires Systemic therapy * Rx: Fluconazole -> CD4 < 50 * **Toxoplasmosis** * Protozoa * Causes Encephalitis * Causes characteristic “ring” lesions on brain * Primary ppx indicated for CD4 < 100 + serum toxo IgG pos. * Rx: High dose Sulfamethoxazole/Trimethoprim * **Disseminated MAC** * Mycobacterium complex * Causes fever, wl, night sweats, GI symptoms * Blood culture or LN biopsy, liver or bone marrow * Rx. Azithro, ethambutol +/- rifabutin * Tx. for minimum of 12 m/o * Primary prevention not indicated when CD4 < 50 and not on ARV's * **CMV** * Cytomegalovirus * Causes retinitis, esophagitis, colitis, neurologic disease * Retinitis Tx. consists of induction followed by maintenance therapy * Ganciclovir or Valganclovir * Intravitreal injections of ganciclovir may be used * **Cryptococcal meningitis** * Cryptococcus neoformans * Yeast * Cryptococcal Antigens (CSF), india link * Rx: 3 phases * Induction (Ampho B + Flucytosine) * Consolidation * Fluconazole High dose * Maintenance * Fluconazole low dose * Tx. for at least 1 year * Delay ARV start if ARV-naive # Primary Prevention | Disease | When to start prophylaxis | Preferred regiment(s) | |---|---|---| | P. Jiroveci pneumonia (PJP) | CD4 <200 or <14% | Cotrimoxazole i DS tab daily or 3x/week | | T. gondii | CD4 <100 and positive serology (toxo IgG) | Cotrimoxazole i single strength tab daily | | Disseminated M. avium complex (MAC) | Only if patient is not on fully suppressive ART AND CD4<50 | Azithromycin 1200 mg once weekly OR 600 mg twice weekly Clarithromycin 500 mg BID |